INDONESIA-SURAKARTA-COVID-19-VACCINATION

INDONESIA-SURAKARTA-COVID-19-VACCINATION

(220322) -- SURAKARTA, March 22, 2022 (Xinhua) -- A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, March 22, 2022. Indonesia's National Agency of Drug and Food Control has approved the use of the Sinopharm COVID-19 vaccine as a booster or the third dose for people aged over 18, the agency's head Penny Lukito said on Tuesday. Currently, Indonesia has six booster vaccines, namely Sinovac, AstraZeneca, Pfizer, Moderna, Janssen, and Sinopharm. (Photo by Bram Selo/Xinhua)

  • Product Code
  • ILEA000944848
  • Registered date
  • 2022/3/22 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 2997 × 1998 pixel
  • Resolution
  • dpi
  • Deployment size
  • 2.25(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    INDONESIA-SUKOHARJO-VACCINATION-COVID-19

    INDONESIA-SUKOHARJO-VACCINATION-COVID-19

    (230228) -- SUKOHARJO, Feb. 28, 2023 (Xinhua) -- A man receives a second booster dose of COVID-19 vaccine in Sukoharjo, Central Java, Indonesia, Feb. 28, 2023. (Photo by Bram Selo/Xinhua)

      Indonesia approves emergency use of China's mRNA COVID-19 vaccine

      STORY: Indonesia approves emergency use of China's mRNA COVID-19 vaccine DATELINE: Oct. 1, 2022 LENGTH: 0:01:17 LOCATION: Jakarta CATEGORY: HEALTH/MEDICINE SHOTLIST: 1. STANDUP (English): SUN LEI, Xinhua correspondent 2. various of press release 3. SOUNDBITE 1 (English): PENNY LUKITO, Head of Indonesia's Food and Drug Monitoring Agency (BPOM) 4. SOUNDBITE 2 (English): ANDREAS DONNY, PT Etana Biotechnologies Indonesia 5. various of mRNA vaccine 6. various of BPOM STORYLINE: The Indonesian food and drug administration (BPOM) has issued an emergency use authorization (EUA) for the mRNA-platform COVID-19 vaccine, AWcorna, developed by Chinese companies. STANDUP (English): SUN LEI, Xinhua correspondent "The Indonesian food and drug authority BPOM has authorized a China-made mRNA vaccine for emergency use in individuals 18 years of age or above, as either primary or booster dose." AWcorna is a SARS-CoV-2 mRNA vaccine developed by Suzhou Abogen Biosciences Co., Ltd. with the participation of Walvax Biotechnolog

        Spain to start administering 4th dose of anti-COVID vaccine

        STORY: Spain to start administering 4th dose of anti-COVID vaccine DATELINE: Sept. 9, 2022 LENGTH: 00:01:38 LOCATION: Madrid CATEGORY: HEALTH SHOTLIST: 1. various of vaccination campaign against COVID-19 2. various of medical investigation center in Madrid 3. various of vaccination campaign against COVID-19 4. various of hospital in Madrid STORYLINE: Spain will start to administer the fourth dose of vaccine against COVID-19 on Sept. 26, said the Ministry of Health on Thursday. The decision was made at a meeting of the Public Health Commission, which includes members from all 17 autonomous communities of the country. People aged over 80 and those who live in nursing homes will be the first to receive the second booster. The ministry said the first batch of vaccines against the Omicron variant will arrive on Friday and will be distributed next week. So far, more than 95 million doses of vaccine have been administered in Spain, with 40 million people having received two doses. Xinhua News Agency c
          INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

          INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

          (220721) -- SURAKARTA, July 21, 2022 (Xinhua) -- A health worker inoculates a man with a booster dose of COVID-19 vaccine at Tirtonadi Bus Station in Surakarta, Central Java, Indonesia, July 21, 2022. (Photo by Bram Selo/Xinhua)
            INDONESIA-FOOT AND MOUTH DISEASE-MEASURES

            INDONESIA-FOOT AND MOUTH DISEASE-MEASURES

            (220704) -- SURAKARTA, July 4, 2022 (Xinhua) -- A health worker sprays disinfectant at goat stalls as a measure to cope with the re-emergence of the foot-and-mouth disease (FMD), which spreads among livestock, in Surakarta, Central Java, Indonesia, July 4, 2022. (Photo by Bram Selo/Xinhua)
              INDONESIA-KARANGANYAR-FMD-VACCINATION

              INDONESIA-KARANGANYAR-FMD-VACCINATION

              (220701) -- KARANGANYAR, July 1, 2022 (Xinhua) -- A staff member from the Animal Health Center wearing protective suit gives a dose of vaccine to a cow during a foot-and-mouth disease (FMD) nationwide livestock vaccination program in Karanganyar, Central Java, Indonesia, July 1, 2022. (Photo by Bram Selo/Xinhua)
                INDONESIA-KARANGANYAR-FMD-VACCINATION

                INDONESIA-KARANGANYAR-FMD-VACCINATION

                (220629) -- KARANGANYAR, June 29, 2022 (Xinhua) -- A staff member from the Animal Health Center gives a dose of vaccine to a cow during a foot-and-mouth disease (FMD) nationwide livestock vaccination program in Karanganyar, Central Java, Indonesia, June 29, 2022. (Photo by Bram Selo/Xinhua)
                  INDONESIA-KARANGANYAR-FMD-VACCINATION

                  INDONESIA-KARANGANYAR-FMD-VACCINATION

                  (220629) -- KARANGANYAR, June 29, 2022 (Xinhua) -- A staff member from the Animal Health Center gives a dose of vaccine to a cow during a foot-and-mouth disease (FMD) nationwide livestock vaccination program in Karanganyar, Central Java, Indonesia, June 29, 2022. (Photo by Bram Selo/Xinhua)
                    INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

                    INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

                    (220607) -- SURAKARTA, June 7, 2022 (Xinhua) -- A health worker inoculates a man with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, June 7, 2022. (Photo by Bram Selo/Xinhua)
                      INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

                      INDONESIA-SURAKARTA-COVID-19-VACCINATION-BOOSTER

                      (220607) -- SURAKARTA, June 7, 2022 (Xinhua) -- A health worker inoculates a woman with a booster dose of COVID-19 vaccine in Surakarta, Central Java, Indonesia, June 7, 2022. (Photo by Bram Selo/Xinhua)